Skip to main content

Find Clinical Trials

Home
Conditions
Tetanus

Clinical trial condition

Tetanus

Explore clinical trials studying Tetanus. Study availability and eligibility vary by location and protocol.

225 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Tetanus trial results

Completed

A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older

NCT00457249

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Chandler, Arizona, United States

Phoenix, Arizona, United States

Cypress, California, United States

San Luis Obispo, California, United States

View all 19 locations

View Trial Details

Completed

Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®

NCT00319553

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Annapolis, Maryland, United States

Baltimore, Maryland, United States

Frederick, Maryland, United States

Durham, North Carolina, United States

View Trial Details

Completed

Immunogenicity and Safety of Pentaxim in South African Infants

NCT00254969

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +26 more
Locations: Soweto, South Africa

View Trial Details

Completed

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

NCT00453570

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +27 more
Locations: Nanning, Guangxi, China

View Trial Details

Completed

Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.

NCT01214889

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +27 more
Locations: Daejeon, South Korea

Gyeionggi Do, South Korea

Gyeonggi-do, South Korea

Gyeonggi-do, South Korea

View all 14 locations

View Trial Details

Completed

Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines

NCT00254917

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +28 more
Locations: Manila, Philippines

View Trial Details

Completed

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

NCT00255021

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +26 more
Locations: Bangkok, Thailand

View Trial Details

Completed

Immunogenicity and Safety of Pentaxim™ in an Indian Population

NCT00259337

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +27 more
Locations: New Delhi, India

View Trial Details

Completed

Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV

NCT00319852

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations: Seoul, South Korea

View Trial Details

Completed

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

NCT00772928

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +28 more
Locations: Montgomery, Alabama, United States

Fayetteville, Arkansas, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

View all 23 locations

View Trial Details